Has Manoj Mittal, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,061 in general payments to Manoj Mittal, MD across 26 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Manoj Mittal, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Manoj Mittal, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Manoj Mittal, MD

Neurocritical Care · Sacramento, CANPI 1528220720

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 26 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 12 manufacturers, the largest accounting for just 19.9% — the pattern of someone who eats at a lot of different presentations.

$1,061in general payments, 2019–2025

Across 26 payments — averaging $40.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$211
Argenx US, Inc.$210
Boston Scientific$180
Lilly USA, LLC$130
GE HealthCare$98
Genentech USA, Inc.$57
plus $174 from 6 others

$21,830in research payments, 2019–2025

Across 12 payments — averaging $1819.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Genentech, Inc.$22K

What the payments were for

Food & beverage$1,061100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	7	$211
Argenx US, Inc.	2	$210
Boston Scientific	2	$180
Lilly USA, LLC	2	$130
GE HealthCare	4	$98
Genentech USA, Inc.	2	$57
Merz Pharmaceuticals, LLC	1	$52
Biogen	2	$45
UCB, Inc.	1	$28
Eisai Inc.	1	$18
AstraZeneca	1	$16
Pfizer	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,061 in reported general payments places this provider in the 75th percentile of 65 neurocritical care providers in California.

See all neurocritical care providers in California →

Medicare billing

Part B allowed, 2024

$104,753

Medicare patients

280

Services billed

564

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurocritical care in Sacramento

Steven YangSacramento$1K
Lara ZimmermannSacramento$888
Ryan MartinSacramento$539
Jaspreet MannSacramento$411
Krupa SavaliaSacramento$192
Jeffrey VittSacramento$56
Saad YazdaniSacramento$42
Nerses SanossianLos Angeles$106K
May Kim-TenserLos Angeles$29K
Wengui YuOrange$22K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →